Concepta PLC (LON:CPT)’s share price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 7 ($0.09) and last traded at GBX 7.40 ($0.10), with a volume of 3941 shares changing hands. The stock had previously closed at GBX 7.30 ($0.10).
Several equities analysts have recently issued reports on CPT shares. Peel Hunt reaffirmed a “buy” rating and set a GBX 120 ($1.62) price target on shares of Concepta in a research note on Monday, September 4th. FinnCap upped their price target on Concepta from GBX 690 ($9.29) to GBX 968 ($13.03) and gave the company a “corporate” rating in a research note on Monday, August 21st. Liberum Capital started coverage on Concepta in a research note on Tuesday, August 15th. They set a “buy” rating and a GBX 850 ($11.44) price target on the stock. Finally, Beaufort Securities reaffirmed a “speculative buy” rating and set a GBX 22 ($0.30) price target on shares of Concepta in a research note on Thursday, August 24th. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Concepta currently has a consensus rating of “Buy” and an average target price of GBX 484.30 ($6.52).
Concepta (LON:CPT) last released its earnings results on Tuesday, September 19th. The company reported GBX (1) (($0.01)) earnings per share for the quarter.
TRADEMARK VIOLATION WARNING: This report was published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://sportsperspectives.com/2017/12/11/concepta-cpt-reaches-new-52-week-low-at-7-00.html.
Concepta Company Profile
Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.
Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with MarketBeat.com's FREE daily email newsletter.